| 2.47 -0.01 (-0.4%) | 11-28 13:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.03 | 1-year : | 3.54 |
| Resists | First : | 2.59 | Second : | 3.03 |
| Pivot price | 2.45 | |||
| Supports | First : | 2.4 | Second : | 2.27 |
| MAs | MA(5) : | 2.44  |
MA(20) : | 2.45 |
| MA(100) : | 2.43 |
MA(250) : | 2.13 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 61 |
D(3) : | 54 |
| RSI | RSI(14): 50.3  |
|||
| 52-week | High : | 3.16 | Low : | 1.6 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CRON ] has closed below upper band by 43.0%. Bollinger Bands are 20.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.51 - 2.52 | 2.52 - 2.53 |
| Low: | 2.42 - 2.44 | 2.44 - 2.45 |
| Close: | 2.46 - 2.48 | 2.48 - 2.49 |
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Tue, 25 Nov 2025
Cronos Group (NASDAQ: CRON) launches Lord Jones live resin pre-rolls in Canada - Stock Titan
Mon, 24 Nov 2025
Hillsdale Investment Management Inc. Makes New Investment in Cronos Group Inc. $CRON - MarketBeat
Sun, 16 Nov 2025
Cronos Group (CRON) Price Target Increased by 104.89% to 3.62 - Nasdaq
Thu, 13 Nov 2025
Quinn Opportunity Partners LLC Purchases 3,138,018 Shares of Cronos Group Inc. $CRON - MarketBeat
Thu, 06 Nov 2025
Cronos Group Reports 2025 Third Quarter Results - GlobeNewswire
Thu, 06 Nov 2025
Cronos Group Inc (CRON) Q3 2025 Earnings: Revenue Misses Estimat - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 383 (M) |
| Shares Float | 202 (M) |
| Held by Insiders | 47 (%) |
| Held by Institutions | 16 (%) |
| Shares Short | 3,160 (K) |
| Shares Short P.Month | 3,230 (K) |
| EPS | 0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.82 |
| Profit Margin | 27.2 % |
| Operating Margin | -13.9 % |
| Return on Assets (ttm) | -1.4 % |
| Return on Equity (ttm) | 3.6 % |
| Qtrly Rev. Growth | 6 % |
| Gross Profit (p.s.) | 0.13 |
| Sales Per Share | 0.34 |
| EBITDA (p.s.) | -0.04 |
| Qtrly Earnings Growth | 238.8 % |
| Operating Cash Flow | 22 (M) |
| Levered Free Cash Flow | -22 (M) |
| PE Ratio | 22.45 |
| PEG Ratio | 0 |
| Price to Book value | 0.87 |
| Price to Sales | 7.14 |
| Price to Cash Flow | 43.48 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|